The miR-17-92 cluster: Yin and Yang in human cancers

Wenyuan Zhao1, Ananya Gupta2, Janusz Krawczyk3

  • 1Discipline of Pathology, Cancer Progression and Treatment Research Group, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland.

Insights

The miR-17-92 cluster, a microRNA (miRNA) regulator, shows dual roles in cancer, acting as both an oncogene and tumor suppressor. Understanding its context-dependent functions is key for developing novel cancer biomarkers and therapeutics.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression involved in critical cellular processes.
  • Dysregulated miRNA expression is linked to human cancer development and progression.
  • The miR-17-92 cluster is a well-studied miRNA group with reported oncogenic and tumor-suppressive roles.

Purpose of the Study:

  • To review the recent advancements and context-dependent roles of the miR-17-92 cluster in various cancers.
  • To summarize mechanisms regulating miR-17-92 expression and its downstream molecular pathways.
  • To discuss its dual role as an oncogene and tumor suppressor, impacting cancer hallmarks.

Main Methods:

  • Literature review of recent progress on miR-17-92 cluster in cancer.
  • Analysis of regulatory mechanisms and molecular pathways controlled by miR-17-92.
  • Discussion of cellular context-dependent effects and targeting strategies.

Main Results:

  • The miR-17-92 cluster exhibits context-dependent oncogenic or tumor-suppressive functions in different cancers.
  • Its expression is tightly regulated, and it impacts key cancer hallmarks through various targets.
  • Cellular context significantly influences the biological effects of the miR-17-92 cluster.

Conclusions:

  • The miR-17-92 cluster's paradoxical roles in cancer are explained by cellular context and regulatory mechanisms.
  • It plays a role in cell fate regulation and can be targeted for cancer therapy.
  • The miR-17-92 cluster holds potential as a prognostic biomarker and therapeutic target in human cancers.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.3K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K